A WHO Ebola vaccine funding review has sparked debate over $60 million in expanded vaccine development using COVID-era platforms. Critics question transparency, while officials emphasize rapid outbreak readiness.
A quiet but consequential debate unfolded in South Carolina as lawmakers rejected a proposal to eliminate religious vaccine exemptions while advancing legislation limiting mandates for infants. The votes highlight a growing national tension between public health policy and parental vaccine rights.
The Cochrane HPV vaccine review controversy is forcing a closer look at how clinical evidence is framed, which data are emphasized, and why critical safety questions remain unresolved.
A wave of reports claimed the U.S. might move toward Denmark’s simpler vaccine schedule — and the media reacted with instant alarm. Instead of encouraging open dialogue about the growing vaccine safety debate, major outlets rushed to shut it down. This investigative rewrite explores how speculation turned into hysteria, why meaningful questions about childhood vaccines are dismissed, and what happens when narrative control replaces careful public health discussion.
A growing debate inside U.S. public health institutions may reshape how millions of newborns are treated in their first hours of life. As the CDC considers ending the universal hepatitis B birth dose for infants of negative-testing mothers, former officials and major media outlets launch a coordinated push to preserve the mandate. Critics highlight a mismatch between risk and policy, concerns over aluminum exposure, and the multibillion-dollar vaccine market driving resistance to change. This quiet but pivotal moment exposes deeper questions about health freedom, informed consent, and whether the future of vaccine policy will prioritize precision or mass mandates.
